Product Benefits:

• Helps reduce the risk of atherothrombotic events (e.g., myocardial infarction, stroke) in adults following acute coronary syndromes with elevated cardiac biomarkers when used alongside aspirin ± clopidogrel/ticlopidine.

• Oral anticoagulant with direct Factor Xa inhibition—blocks clot formation by interfering with both intrinsic and extrinsic coagulation pathways.

• Convenient low dose (2.5 mg) tablet allows adjunctive therapy in selected cardiovascular‑risk populations.

• Locally manufactured by Eskayef in Bangladesh—improves accessibility and local availability.